These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21568258)

  • 21. [Fluoxetine--safe during pregnancy and breast feeding].
    Pomp EF; Gedde-Dahl A
    Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1156-7. PubMed ID: 11354903
    [No Abstract]   [Full Text] [Related]  

  • 22. Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.
    da Rocha FF; Correa H
    Braz J Psychiatry; 2007 Mar; 29(1):94. PubMed ID: 17435946
    [No Abstract]   [Full Text] [Related]  

  • 23. Antidepressants and testicular cancer.
    Friedman GD; Schwalbe J; Achacoso N; Meng MV; Kroenke CH; Habel LA
    Cancer Causes Control; 2014 Feb; 25(2):251-8. PubMed ID: 24276357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic appraisal of citalopram in the management of single-episode depression.
    Sclar DA; Skaer TL; Robison LM; Galin RS
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of fluoxetine-induced sexual dysfunction by switching to escitalopram.
    Ashton AK
    J Sex Marital Ther; 2004; 30(1):1-2. PubMed ID: 14660288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 27. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
    Bakish D
    Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
    Corruble E; Guelfi JD
    Encephale; 1999 Jun; 25 Spec No 2():39-43; discussion 44-6. PubMed ID: 10434158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacologic therapy of depression during pregnancy].
    Bellantuono C; Migliarese G; Imperadore G
    Recenti Prog Med; 2006 Feb; 97(2):94-107. PubMed ID: 16671276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal depression: guidelines for when to use pharmacotherapy.
    Bot ST
    JAAPA; 2008 Sep; 21(9):24-30. PubMed ID: 18822587
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.
    Rubino A; Roskell N; Tennis P; Mines D; Weich S; Andrews E
    BMJ; 2007 Feb; 334(7587):242. PubMed ID: 17164297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between antidepressant use during pregnancy and infants born small for gestational age.
    Ramos É; St-André M; Bérard A
    Can J Psychiatry; 2010 Oct; 55(10):643-52. PubMed ID: 20964943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal exposure to antidepressants: how safe are they?
    Steiner M
    Am J Psychiatry; 2012 Nov; 169(11):1130-2. PubMed ID: 23128917
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-response relationship with venlafaxine.
    Kelsey JE
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):21S-26S; discussion 26S-28S. PubMed ID: 8784645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
    Alfaro CL; Lam YW; Simpson J; Ereshefsky L
    J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.
    Chua EW; Foulds J; Miller AL; Kennedy MA
    Pharmacogenet Genomics; 2013 Sep; 23(9):494-7. PubMed ID: 23799451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.